You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 3, March 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pharmacologic and Surgical Enhancement of Composite Graft Survival

Patrick C. Fann, MD; Daniel F. Hartman, MD; Richard L. Goode, MD

Arch Otolaryngol Head Neck Surg. 1993;119(3):313-319.


Abstract

• A previously described rabbit ear model was used to address the following issues: (1) the role of surgical delay in composite tissue transfer, (2) optimal enhancement of graft survival using the corticosteroid methylprednisolone, (3) pharmacologic salvage of the failing composite graft, and (4) efficacy of a nonsteroidal dual cyclooxygenase/lipooxygenase inhibitor (SK&F 86002) in enhancing graft survival. Preoperative and immediate postoperative steroid treatment groups exhibited a significant improvement in graft survival area compared with the untreated control group. Preoperative initiation of steroid therapy was more effective than a strictly postoperative regimen. SK&F 86002, advance preparation of the recipient bed, and delayed steroid administration did not improve graft survival compared with the untreated control group. The most promising treatment, preoperative initiation of steroid therapy, was further evaluated in a double-blinded placebo-controlled study. The steroid group demonstrated a significantly improved mean survival area, as well as mean graft weight, compared with the placebo control group.

(Arch Otolaryngol Head Neck Surg. 1993;119:313-319)



Author Affiliations

From the Division of Otolaryngology—Head and Neck Surgery, Stanford (Calif) University (Drs Fann and Goode) and the University of California San Francisco (Dr Hartman). Dr Fann is now doing a fellowship with Walter E. Berman, MD, in private practice in Beverly Hills, Calif.


Footnotes

Accepted for publication October 9, 1992.

Read before the Spring Meeting of the American Academy of Facial Plastic and Reconstructive Surgery, Palm Desert, Calif, April 11, 1992.

Reprint requests to Division of Otolaryngology—Head Neck Surgery, R-145, Stanford University Medical Center, Standford, CA 90305 (Dr Goode).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of hyperbaric oxygen to enhance auricular composite graft survival in the rabbit model.
Lewis et al.
Arch Facial Plast Surg 2006;8:310-313.
ABSTRACT | FULL TEXT  

Composite Graft Survival: An Auricular Amputation Model
Henrich et al.
Arch Otolaryngol Head Neck Surg 1995;121:1137-1142.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.